Epiphora in lung cancer patients receiving docetaxel: a case series

BACKGROUND: Docetaxel is a key antineoplastic drug for treatment of non-small cell lung cancer. Ocular adverse events of docetaxel include epiphora (excess tearing) and conjunctivitis. Epiphora has been reported to be associated with canalicular and nasolacrimal duct stenosis, but it is not necessar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamagishi, Tomoko, Ochi, Nobuaki, Yamane, Hiromichi, Hasebe, Satoshi, Takigawa, Nagio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046091/
https://www.ncbi.nlm.nih.gov/pubmed/24886618
http://dx.doi.org/10.1186/1756-0500-7-322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046091/
https://www.ncbi.nlm.nih.gov/pubmed/24886618
http://dx.doi.org/10.1186/1756-0500-7-322

Ejemplares similares